featured-Reporter

Proton transfer powers multidrug resistance: study

Vanderbilt University researchers and their Belgian colleagues have discovered the mechanism behind a multidrug transporter. Their findings, posted this week by Nature Chemical Biology, could lead to new treatments for multidrug resistant bacterial infections.

VU study points to central regulator of neuron development

Developmental biologist Chin Chiang, Ph.D., and his colleagues have discovered that Purkinje neurons in the cerebellum act as central regulators of neuronal development.

GE grant expands global medical outreach efforts

Vanderbilt University has received a $3 million grant from the GE Foundation’s Developing Health Globally program to fund international medical education and research in Kenya and other low-resource regions of the world.

Pioneers of Discovery: Investigator explores how cells decide what’s on surface

Jason MacGurn, Ph.D., a new assistant professor of Cell and Developmental Biology at Vanderbilt, is studying how cells make decisions about the protein composition of the cell surface.

Andries Zijlstra, Ph.D., and colleagues are studying a biomarker that can help predict prostate cancer recurrance. (photo by Susan Urmy)

Predictor of prostate cancer outcomes identified

Researchers at Vanderbilt University Medical Center and the University of Alberta in Canada have identified a biomarker for a cellular switch that accurately predicts which prostate cancer patients are likely to have their cancer recur or spread.

Program helps children with complex care needs

David Hall, M.D., has joined the Monroe Carell Jr. Children’s Hospital at Vanderbilt as professor of Clinical Pediatrics and the director of the new Program for Children with Medically Complex Needs within the Division of Hospital Medicine.

1 117 118 119 120 121 151